美国法官再次驳回强生公司试图利用破产处理滑石粉致癌索赔的请求-动脉网

US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims

benzinga 等信源发布 2025-04-01 09:51



可切换为仅中文







A U.S. bankruptcy court in Texas has rejected

德克萨斯州的一家美国破产法院拒绝了

Johnson & Johnson’s

强生公司的

JNJ

强生公司

subsidiary Red River Talc's request to approve its prepackaged bankruptcy plan. The company said the plan included one of the largest settlements in mass tort bankruptcy history and was

子公司的红河滑石粉公司请求批准其预先打包的破产计划。该公司表示，该计划包含了大规模侵权破产历史上最大的和解之一，并且是

backed by most claimants

得到大多数索赔人的支持

。

In October 2024, the Department of Justice’s unit argued that Johnson & Johnson’s latest bankruptcy maneuver is a bad-faith attempt to shield itself from billions in personal injury claims without actually entering bankruptcy.

2024年10月，美国司法部部门辩称，强生公司最新的破产策略是试图在不真正进入破产程序的情况下，以不良动机保护自己免受数十亿人身伤害索赔的影响。

Instead of appealing the decision, Red River Talc will return to the court system to fight what it calls baseless

雷德河滑石公司没有对这一裁决提出上诉，而是将返回法院系统，以对抗它所谓的毫无根据的指控。

talc-related lawsuits

滑石粉相关诉讼

。

The company claims that disclosures during the bankruptcy process confirmed the litigation is driven by plaintiff lawyers, based on flawed science and funded by outside investors, including foreign sovereign wealth funds.

公司声称，破产程序期间的披露证实，诉讼是由原告律师推动的，基于有缺陷的科学，并由包括外国主权财富基金在内的外部投资者提供资金。

Also Read:

另请阅读：

Justice Department’s Trustee Program Alleges Johnson & Johnson’s Talc Litigation Bankruptcy Bid Is Bad-Faith Tactic To Avoid Liability

司法部的信托人计划指控强生公司提出的滑石粉诉讼破产申请是一种规避责任的恶意策略。

As a result, the company has no plans to settle and will reverse about $7 billion previously

因此，该公司不打算解决问题，并将扭转此前约70亿美元的局面。

set aside for legal costs

为法律费用留出资金

。

“The Court has unfortunately allowed a couple of law firms with financially conflicted motives, who have conceded they have not recovered a dime for their clients in a decade of litigation, to defeat the overwhelming desire of claimants. As we have repeatedly stated, in the absence of plan confirmation, we will vigorously present our case in the tort system, starting with the adjudication of the motions pending in the Multi-District Litigation to exclude plaintiffs’ experts and to disqualify the lead counsel for its unethical breaches,” said .

“遗憾的是，法院竟然允许几家存在财务利益冲突的律师事务所胜诉，这些律所已经承认在长达十年的诉讼中没有为他们的客户追回一分钱，从而挫败了索赔人的强烈愿望。我们已多次声明，在缺乏计划确认的情况下，我们将从多方诉讼中待决动议的裁决开始，积极在侵权法体系中陈述我们的案情，以排除原告方的专家，并取消因不道德违规行为而使首席律师资格不保。”

Erik Haas

埃里克·哈斯

, Worldwide VP of Litigation, Johnson & Johnson. “We prevailed in 16 of 17 ovarian cases tried in the last 11 years and will devote our efforts to defeating these fake claims.”

，强生公司全球诉讼副总裁。“在过去的11年里，我们赢得了17起卵巢癌案件中的16起，我们将致力于击败这些虚假的指控。”

“Today’s decision highlights the broken tort system in the United States. The company reiterates that none of the talc-related claims against it have merit and attempts to resolve this litigation were aimed at moving past this issue,” Haas continued. “The decision to litigate every filed case is based on the simple fact that this is a fake claim created by greedy plaintiff lawyers looking for another deep pocket to sue and fueled by litigation-financed attorney advertising.”.

“今天的判决突显了美国侵权制度的缺陷。公司重申，针对其所有的滑石粉相关诉讼均无事实依据，尝试解决这一诉讼的目的在于结束这个问题，”哈斯继续说道。“决定对每一个提起的案件进行诉讼，是基于一个简单的事实，即这是一个由贪婪的原告律师为了寻找另一个有钱的被告而捏造的虚假索赔，并且受到诉讼资助的律师广告的推动。”

In September,

九月，

Johnson & Johnson

强生公司

reportedly increased its settlement offer by $1 billion, now totaling about $9 billion, to address claims that its talc baby powder

据报道，其和解报价增加了 10 亿美元，总额现在约为 90 亿美元，以解决其滑石粉婴儿爽身粉相关的索赔问题。

caused gynecological cancer

导致妇科癌症

。

Price Action:

价格行为:

JNJ stock is down 3.48% at $160.07 during the premarket session at the last check Tuesday.